Drug Profile
TMC 003
Latest Information Update: 04 Feb 2017
Price :
$50
*
At a glance
- Originator Targeted Molecules Corporation
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Kidney disorders
Most Recent Events
- 03 Feb 2017 Discontinued - Preclinical for Kidney disorders in USA (unspecified route)
- 08 Feb 2005 Suspended - Preclinical for Kidney disorders in USA (unspecified route)
- 25 Mar 2003 Preclinical trials in Kidney disorders in USA (unspecified route)